Stevens-Johnson syndrome: Difference between revisions

From IDWiki
Β 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
   
βˆ’
== Etiology ==
+
==Etiology==
  +
βˆ’
* Infection: especially common in children
+
*Infection: especially common in children
βˆ’
** [[Mycoplasma pneumoniae]]: moderate to severe involvement of two or more mucosal sites and sparse, or even absent, skin involvement
+
**[[Mycoplasma pneumoniae]]: moderate to severe involvement of two or more mucosal sites and sparse, or even absent, skin involvement
βˆ’
** [[Neisseria gonorrhoeae]][[CiteRef::tan2012pr]]
+
**[[Neisseria gonorrhoeae]][[CiteRef::tan2012pr]]
βˆ’
* Drugs
+
*Drugs
βˆ’
** Allopurinol
+
**[[Allopurinol]]
βˆ’
** Aromatic antiepileptic drugs and lamotrigine
+
**Aromatic [[antiepileptic drugs]] and [[lamotrigine]]
βˆ’
** Antibacterial sulfonamides (including [[sulfamethoxazole]] and sulfasalazine)
+
**Antibacterial sulfonamides (including [[sulfamethoxazole]] and [[sulfasalazine]])
βˆ’
** [[Nevirapine]]
+
**[[Nevirapine]]
βˆ’
** Oxicam nonsteroidal anti-inflammatory drugs (NSAIDs)
+
**[[Oxicam]] nonsteroidal anti-inflammatory drugs (NSAIDs)
βˆ’
** Less strongly, other antibiotics
+
**Less strongly, other antibiotics
βˆ’
*** [[Doxycycline]]
 
βˆ’
*** [[Amoxicillin]]/[[ampicillin]]
+
***[[Doxycycline]]
βˆ’
*** [[Ciprofloxacin]]
+
***[[Amoxicillin]]/[[ampicillin]]
βˆ’
*** [[Levofloxacin]]
+
***[[Ciprofloxacin]]
βˆ’
*** [[Rifampin]]
+
***[[Levofloxacin]]
  +
***[[Rifampin]]
  +
  +
== Management ==
  +
  +
* Risk stratify with [[SCORTEN score]]
  +
* Consider referral to burn centre or ICU if [[BSA]] 30% or greater, or if SCORTEN score is 2 or greater
  +
*Stop offending drug, if applicable
  +
*Supportive care, including wound care and IV fluids (2 ml per kg times BSA over first 24 hours)
  +
**Room temperature 30ΒΊ to 32ΒΊC
  +
**May need NG tube
  +
**Pain control, as pain may be severe
  +
*Ophthalmologic exam and management
  +
**Saline rinses
  +
**Artificial tears even if no involvement
  +
**Corticosteroids with or without antibiotics for any involvement
  +
*No clear benefit to steroids or IVIG
  +
*Cyclosporine 3 to 5 mg per kg in one or two divided doses may slow progression

Latest revision as of 09:39, 10 April 2024

Etiology

Management

  • Risk stratify with SCORTEN score
  • Consider referral to burn centre or ICU if BSA 30% or greater, or if SCORTEN score is 2 or greater
  • Stop offending drug, if applicable
  • Supportive care, including wound care and IV fluids (2 ml per kg times BSA over first 24 hours)
    • Room temperature 30ΒΊ to 32ΒΊC
    • May need NG tube
    • Pain control, as pain may be severe
  • Ophthalmologic exam and management
    • Saline rinses
    • Artificial tears even if no involvement
    • Corticosteroids with or without antibiotics for any involvement
  • No clear benefit to steroids or IVIG
  • Cyclosporine 3 to 5 mg per kg in one or two divided doses may slow progression

References

  1. ^  SK Tan, YK Tay. Profile and Pattern of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a General Hospital in Singapore: Treatment Outcomes. Acta Dermato Venereologica. 2012;92(1):62-66. doi:10.2340/00015555-1169.